"10.1371_journal.pone.0106346","plos one","2014-09-04T00:00:00Z","Chung-Hsing Chou; John D Sinden; Pierre-Olivier Couraud; Michel Modo","University of Pittsburgh, McGowan Institute for Regenerative Medicine, Pittsburgh, Pennsylvania, United States of America; Kings College London, Institute of Psychiatry, Department of Neuroscience, London, United Kingdom; Tri-service General Hospital, Department of Neurology, National Defense Medical Centre, Taipei, Taiwan; ReNeuron Ltd, Guildford, Surrey, United Kingdom; INSERM U1016, Institut Cochin, Paris, France; CNRS, UMR8104, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; University of Pittsburgh, Department of Radiology, Pittsburgh, Pennsylvania, United States of America; University of Pittsburgh, Department of Bioengineering, Pittsburgh, Pennsylvania, United States of America","Conceived and designed the experiments: CHC MM. Performed the experiments: CHC. Analyzed the data: CHC MM. Contributed reagents/materials/analysis tools: JDS POC. Wrote the paper: CHC JDS POC MM.","Dr. John Sinden is an employee of ReNeuron Ltd. The cell lines described here are subject to patents, notably the D3 cell line is covered under patent WO200605679A1 and the STROC05 cell line is covered under patent US7666672. These cells are available through Material Transfer Agreement. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.","2014","09","Chung-Hsing Chou","CHC",4,TRUE,2,1,2,4,TRUE,TRUE,FALSE,0,NA,FALSE
